{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"pt-141-post-surgery","title":"PT-141 for Post-Surgery: Sexual and CNS Arousal Pathways in Recovery","body":"## What's breaking down\n\nPost-surgery recovery often involves layers of change that extend beyond the surgical site itself. Nerve disruption, hormonal shifts, reduced mobility, and psychological stress can affect multiple systems. One relevant layer for many patients is sexual function and central nervous system (CNS) arousal pathways. Surgery such as prostate procedures can alter nerve signaling and hormone levels, leading to diminished sexual desire even when physical capacity for orgasm remains. This creates a mismatch where mechanical responses may be addressable but the drive and arousal signals from the brain are reduced. The condition persists when repair processes in these neural and motivational pathways lag behind the degenerative effects of the procedure and recovery period.\n\n## Why PT-141 might help you\n\nPT-141 targets the sexual and CNS arousal layer. If that layer is part of your problem after surgery, PT-141 is discussed because it acts on melanocortin receptors in the hypothalamus to enhance arousal signals at the source in the brain.\n\n1. Therefore for you: If your post-surgery experience includes reduced sexual thoughts or motivation despite preserved physical capability, the CNS-focused action aligns with addressing the arousal pathway directly.\n2. Therefore for you: If conventional approaches focus only on blood flow or local tissue, PT-141 operates upstream in the brain, potentially supporting the motivational component of recovery rather than masking symptoms.\n3. Therefore for you: If nerve or hormonal changes from surgery have dampened desire pathways, activating MC4 receptors may promote dopamine release involved in sexual motivation, fitting a repair-oriented discussion of those specific circuits.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- **PT-141** → sexual / CNS arousal\n\n## What the evidence actually shows\n\nHuman data comes primarily from trials in hypoactive sexual desire disorder (HSDD). Two Phase 3 randomized controlled trials (BMT-301 and BMT-302) enrolled over 1,200 premenopausal women and tested subcutaneous bremelanotide 1.75 mg as-needed versus placebo. These showed statistically significant improvements in sexual desire scores and reduced distress compared to placebo (human tier). A long-term open-label extension followed participants for up to 18 months and reported sustained effects with manageable side effects in completers (human tier). Earlier smaller studies measured physiological arousal via vaginal pulse amplitude after erotic stimuli and found greater increases with bremelanotide than placebo in healthy women and those with arousal disorder (human tier, small n).\n\nNo dedicated human trials specifically examine PT-141 after surgery. Mentions of post-prostatectomy use appear in clinical discussion articles but lack controlled data (anecdotal/mechanistic tier). Animal studies demonstrate melanocortin agonism increasing sexual behaviors in rodents via hypothalamic pathways (preclinical tier). These do not directly model human post-surgical states.\n\nReddit anecdotes describe subjective increases in arousal or desire after injection, with onset in 1-6 hours and variable duration, alongside reports of nausea or flushing (anecdotal tier). X posts echo similar user experiences of heightened motivation but remain self-reported without controls.\n\n## What scientists say\n\nResearchers describe bremelanotide as a nonselective melanocortin receptor agonist with primary action at MC4R in the medial preoptic area of the hypothalamus, leading to increased dopamine release in reward and motivation circuits (mechanistic tier from reviews). This central mechanism differentiates it from peripheral vasodilators. Scientists note the absence of large post-surgical human datasets and emphasize that approved use remains limited to HSDD in premenopausal women.\n\n## What people say on Reddit\n\nUsers in peptide communities report trying PT-141 for libido concerns that emerged or persisted after procedures. Common themes include noticeable waves of arousal within hours of dosing and effects lasting into the next day for some. Side-effect mentions frequently include transient nausea, flushing, or headache. Experiences vary widely, with some noting no effect on first use.\n\n## What people say on X\n\nPosts reference personal use for arousal enhancement, often describing rapid onset of sexual thoughts or responsiveness. Timing relative to activity and individual dosing experiments appear frequently. Side-effect discussions mirror Reddit patterns. No large verified threads or expert threads dominate recent activity.\n\n## What we do not know\n\nDirect evidence for PT-141 in post-surgical populations is absent from controlled human trials. Long-term effects on neural repair pathways after surgery remain unstudied. Interactions with common post-operative medications or healing timelines lack specific data. Optimal timing relative to surgical recovery stages is unknown.\n\n## Safety and limits\n\nReported effects in trials include nausea, flushing, and injection-site reactions, with most described as mild to moderate (human tier). The compound carries a boxed warning for blood-pressure increases in its approved formulation. Individual responses differ, and self-experimentation carries unknown risks outside monitored settings. All information here is for research discussion only; consult qualified professionals for personal health decisions.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/pt-141-post-surgery/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"Two Phase 3 RCTs (BMT-301, BMT-302) showed statistically significant improvements in sexual desire scores with bremelanotide 1.75 mg vs placebo in women with HSDD.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes the primary human efficacy data tier for the compound's approved indication.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:07.221Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"No dedicated randomized human trials examine PT-141 specifically in post-surgical populations.","section":"What we do not know","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Clarifies the evidence gap for the article's specific context.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:07.221Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Bremelanotide acts as an MC4R agonist in the hypothalamus, increasing dopamine release in motivation circuits.","section":"What scientists say","tier":"mechanistic","source_ids":["s3"],"source_status":"sourced","why_material":"Provides the core mechanism explanation tied to the CNS arousal layer.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:07.221Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"User reports on Reddit describe subjective arousal increases 1-6 hours after PT-141 injection with variable side effects like nausea.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s4"],"source_status":"sourced","why_material":"Documents real-world anecdotal layer separate from trials.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:07.221Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"clinical_trial","url":"https://clinicaltrials.gov/study/NCT01382719","title":"Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder","quote":"This trial is designed to evaluate the efficacy and safety of 3 fixed dose levels of bremelanotide...","summary":"Phase 3 trial details supporting HSDD efficacy data.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:11:06.835Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"b37ba9f623c01df7436e68e9bf724e6497f8f74017b8f526eb5785cf8b6decf7"},{"id":"s2","type":"other","url":"https://www.bostonmedicalgroup.com/pt-141-low-libido-after-prostate-surgery/","title":"Can the PT-141 Peptide Improve Low Libido After Prostate Surgery?","quote":"In this article, we'll explore whether PT-141 for low libido may help men regain sexual desire...","summary":"Clinical discussion noting post-surgery context but no new trial data.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:11:06.835Z","link_status":"ok","quote_status":"unverified","prev":"b37ba9f623c01df7436e68e9bf724e6497f8f74017b8f526eb5785cf8b6decf7","hash":"e38ee0c5739b289b8e4e11c09c118a17d41103a42c1b6989ecb0686cc871f5c4"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/33455598/","title":"The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder","quote":"Bremelanotide may affect female sexual desire by activating presynaptic MC4Rs on neurons in the mPOA of the hypothalamus, leading to increased release of DA.","summary":"Mechanism review detailing CNS action.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:11:06.835Z","link_status":"ok","quote_status":"unverified","prev":"e38ee0c5739b289b8e4e11c09c118a17d41103a42c1b6989ecb0686cc871f5c4","hash":"f1b595db88fc864cde3f2e5e4b61bea8677f992b83deb6803e64da671e30b253"},{"id":"s4","type":"reddit","url":"https://www.reddit.com/r/Peptides/comments/1f9yows/pt141_major_success/","title":"PT-141 Major Success!","quote":"The effect comes on about 2 hours after injection and goes on strongly for at least 18 hours...","summary":"Example anecdotal report of timing and effects.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:11:06.835Z","link_status":"ok","quote_status":"unverified","prev":"f1b595db88fc864cde3f2e5e4b61bea8677f992b83deb6803e64da671e30b253","hash":"63b723640f12cc821fc5128dce68d3fcd78ec5f9ae67932d7634d70e2c6ae3b6"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T01:11:07.638Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"PT-141 for Post-Surgery: Sexual and CNS Arousal Pathways in Recovery","register":"source_ledger","body":"## What's breaking down\n\nPost-surgery recovery often involves layers of change that extend beyond the surgical site itself. Nerve disruption, hormonal shifts, reduced mobility, and psychological stress can affect multiple systems. One relevant layer for many patients is sexual function and central nervous system (CNS) arousal pathways. Surgery such as prostate procedures can alter nerve signaling and hormone levels, leading to diminished sexual desire even when physical capacity for orgasm remains. This creates a mismatch where mechanical responses may be addressable but the drive and arousal signals from the brain are reduced. The condition persists when repair processes in these neural and motivational pathways lag behind the degenerative effects of the procedure and recovery period.\n\n## Why PT-141 might help you\n\nPT-141 targets the sexual and CNS arousal layer. If that layer is part of your problem after surgery, PT-141 is discussed because it acts on melanocortin receptors in the hypothalamus to enhance arousal signals at the source in the brain.\n\n1. Therefore for you: If your post-surgery experience includes reduced sexual thoughts or motivation despite preserved physical capability, the CNS-focused action aligns with addressing the arousal pathway directly.\n2. Therefore for you: If conventional approaches focus only on blood flow or local tissue, PT-141 operates upstream in the brain, potentially supporting the motivational component of recovery rather than masking symptoms.\n3. Therefore for you: If nerve or hormonal changes from surgery have dampened desire pathways, activating MC4 receptors may promote dopamine release involved in sexual motivation, fitting a repair-oriented discussion of those specific circuits.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- **PT-141** → sexual / CNS arousal\n\n## What the evidence actually shows\n\nHuman data comes primarily from trials in hypoactive sexual desire disorder (HSDD). Two Phase 3 randomized controlled trials (BMT-301 and BMT-302) enrolled over 1,200 premenopausal women and tested subcutaneous bremelanotide 1.75 mg as-needed versus placebo. These showed statistically significant improvements in sexual desire scores and reduced distress compared to placebo (human tier). A long-term open-label extension followed participants for up to 18 months and reported sustained effects with manageable side effects in completers (human tier). Earlier smaller studies measured physiological arousal via vaginal pulse amplitude after erotic stimuli and found greater increases with bremelanotide than placebo in healthy women and those with arousal disorder (human tier, small n).\n\nNo dedicated human trials specifically examine PT-141 after surgery. Mentions of post-prostatectomy use appear in clinical discussion articles but lack controlled data (anecdotal/mechanistic tier). Animal studies demonstrate melanocortin agonism increasing sexual behaviors in rodents via hypothalamic pathways (preclinical tier). These do not directly model human post-surgical states.\n\nReddit anecdotes describe subjective increases in arousal or desire after injection, with onset in 1-6 hours and variable duration, alongside reports of nausea or flushing (anecdotal tier). X posts echo similar user experiences of heightened motivation but remain self-reported without controls.\n\n## What scientists say\n\nResearchers describe bremelanotide as a nonselective melanocortin receptor agonist with primary action at MC4R in the medial preoptic area of the hypothalamus, leading to increased dopamine release in reward and motivation circuits (mechanistic tier from reviews). This central mechanism differentiates it from peripheral vasodilators. Scientists note the absence of large post-surgical human datasets and emphasize that approved use remains limited to HSDD in premenopausal women.\n\n## What people say on Reddit\n\nUsers in peptide communities report trying PT-141 for libido concerns that emerged or persisted after procedures. Common themes include noticeable waves of arousal within hours of dosing and effects lasting into the next day for some. Side-effect mentions frequently include transient nausea, flushing, or headache. Experiences vary widely, with some noting no effect on first use.\n\n## What people say on X\n\nPosts reference personal use for arousal enhancement, often describing rapid onset of sexual thoughts or responsiveness. Timing relative to activity and individual dosing experiments appear frequently. Side-effect discussions mirror Reddit patterns. No large verified threads or expert threads dominate recent activity.\n\n## What we do not know\n\nDirect evidence for PT-141 in post-surgical populations is absent from controlled human trials. Long-term effects on neural repair pathways after surgery remain unstudied. Interactions with common post-operative medications or healing timelines lack specific data. Optimal timing relative to surgical recovery stages is unknown.\n\n## Safety and limits\n\nReported effects in trials include nausea, flushing, and injection-site reactions, with most described as mild to moderate (human tier). The compound carries a boxed warning for blood-pressure increases in its approved formulation. Individual responses differ, and self-experimentation carries unknown risks outside monitored settings. All information here is for research discussion only; consult qualified professionals for personal health decisions.","claims":[{"id":"c1","text":"Two Phase 3 RCTs (BMT-301, BMT-302) showed statistically significant improvements in sexual desire scores with bremelanotide 1.75 mg vs placebo in women with HSDD.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes the primary human efficacy data tier for the compound's approved indication.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:07.221Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"No dedicated randomized human trials examine PT-141 specifically in post-surgical populations.","section":"What we do not know","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Clarifies the evidence gap for the article's specific context.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:07.221Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Bremelanotide acts as an MC4R agonist in the hypothalamus, increasing dopamine release in motivation circuits.","section":"What scientists say","tier":"mechanistic","source_ids":["s3"],"source_status":"sourced","why_material":"Provides the core mechanism explanation tied to the CNS arousal layer.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:07.221Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"User reports on Reddit describe subjective arousal increases 1-6 hours after PT-141 injection with variable side effects like nausea.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s4"],"source_status":"sourced","why_material":"Documents real-world anecdotal layer separate from trials.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:07.221Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"clinical_trial","url":"https://clinicaltrials.gov/study/NCT01382719","title":"Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder","quote":"This trial is designed to evaluate the efficacy and safety of 3 fixed dose levels of bremelanotide...","link_status":"ok","quote_status":"unverified"},{"id":"s2","type":"other","url":"https://www.bostonmedicalgroup.com/pt-141-low-libido-after-prostate-surgery/","title":"Can the PT-141 Peptide Improve Low Libido After Prostate Surgery?","quote":"In this article, we'll explore whether PT-141 for low libido may help men regain sexual desire...","link_status":"ok","quote_status":"unverified"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/33455598/","title":"The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder","quote":"Bremelanotide may affect female sexual desire by activating presynaptic MC4Rs on neurons in the mPOA of the hypothalamus, leading to increased release of DA.","link_status":"ok","quote_status":"unverified"},{"id":"s4","type":"reddit","url":"https://www.reddit.com/r/Peptides/comments/1f9yows/pt141_major_success/","title":"PT-141 Major Success!","quote":"The effect comes on about 2 hours after injection and goes on strongly for at least 18 hours...","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":24502,"tokens_out":2975,"cost":0.038065,"prev_hash":"genesis","hash":"6fac8f608bac198b5d02b16e9415d326ec35941d73a17612068693f2c9c85d6e"}],"provenance":[{"ts":"2026-06-30T01:11:07.638Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: PT 141 for Post Surgery\nSlug: pt-141-post-surgery\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"pt-141\",\"name\":\"PT-141\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"pt-141\",\"name\":\"PT-141\",\"section_title\":\"Why PT-141 might help you\",\"layer\":\"sexual / CNS arousal\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **PT-141** → sexual / CNS arousal\",\"section_headings\":[\"What's breaking down\",\"Why PT-141 might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not merge into one peptide essay.\",\"Each Why section must use if-then steps from","response":"{\n  \"slug\": \"pt-141-post-surgery\",\n  \"title\": \"PT-141 for Post-Surgery: Sexual and CNS Arousal Pathways in Recovery\",\n  \"body\": \"## What's breaking down\\n\\nPost-surgery recovery often involves layers of change that extend beyond the surgical site itself. Nerve disruption, hormonal shifts, reduced mobility, and psychological stress can affect multiple systems. One relevant layer for many patients is sexual function and central nervous system (CNS) arousal pathways. Surgery such as prostate procedures can alter nerve signaling and hormone levels, leading to diminished sexual desire even when physical capacity for orgasm remains. This creates a mismatch where mechanical responses may be addressable but the drive and arousal signals from the brain are reduced. The condition persists when repair processes in these neural and motivational pathways lag behind the degenerative effects of the procedure and recovery period.\\n\\n## Why PT-141 might help you\\n\\nPT-141 targets the sexual and CNS arousal layer. If that layer is part of your problem after surgery, PT-141 is discussed because it acts on melanocortin receptors in the hypothalamus to enhance arousal signals at the source in the brain.\\n\\n1. Therefore for you: If your post-surgery experience includes reduced sexual thoughts or motivation despite preserved physical capability, the CNS-focused action aligns with addressing the arousal pathway directly.\\n2. Therefore for you: If conventional approaches focus only on blood flow or local tissue, PT-141 operates upstream in the brain, potentially supporting the motivational component of recovery rather than masking symptoms.\\n3. Therefore for you: If nerve or hormonal changes from surgery have dampened desire pathways, activating MC4 receptors may promote dopamine release involved in sexual motivation, fitting a repair-oriented discussion of those specific circuits.\\n\\n## How these fit together\\n\\nSingle-compound focus — if your condition profile includes a multi-peptide sta","tokens_in":24502,"tokens_out":2975,"cost":0,"prev":"genesis","hash":"8cde3da0f7d91cdd6364f726500ed318eff8ebed2e2bc23f37d967b27808a88d"},{"ts":"2026-07-17T02:41:09.189Z","model":"owner","action":"voxel_divide","prompt":"","input":"pt-141-post-surgery","response":"22 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"8cde3da0f7d91cdd6364f726500ed318eff8ebed2e2bc23f37d967b27808a88d","hash":"eb64b4e74da8b513fc0582020abcdd06a15ae3c976eccbe7dc650618dfd4b673"}],"energy":{"passes":2,"tokens_in":24502,"tokens_out":2975,"tokens_total":27477,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"eb64b4e74da8b513fc0582020abcdd06a15ae3c976eccbe7dc650618dfd4b673"},"posted_at":"2026-06-29T21:32:54.884Z","created_at":"2026-06-29T21:32:54.884Z","updated_at":"2026-07-17T02:41:09.189Z","machine":{"shape":"article.machine/v1","slug":"pt-141-post-surgery","kind":"article","read":{"human":"https://miscsubjects.com/a/pt-141-post-surgery","json":"https://miscsubjects.com/api/articles/pt-141-post-surgery","bundle":"https://miscsubjects.com/api/articles/pt-141-post-surgery/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":4,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/pt-141-post-surgery/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=pt-141-post-surgery","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"pt-141-post-surgery\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"pt-141-post-surgery\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/pt-141-post-surgery/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"pt-141-post-surgery\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/pt-141-post-surgery | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/pt-141-post-surgery","json":"/api/articles/pt-141-post-surgery","markdown":"/api/articles/pt-141-post-surgery/bundle?format=markdown","skill":"/api/articles/pt-141-post-surgery/skill","topology":"/api/articles/pt-141-post-surgery/topology","versions":"/api/articles/pt-141-post-surgery/revisions","invocations":"/api/articles/pt-141-post-surgery/invocations"},"editorial_review":null,"editorial_audit":{"slug":"pt-141-post-surgery","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"017d04c9626a675076cb1536225564c787d4219f3427cafb9d02edb2ac8ab73f","object":{"object_type":"article-object","identity":{"id":"article:pt-141-post-surgery","slug":"pt-141-post-surgery","title":"PT-141 for Post-Surgery: Sexual and CNS Arousal Pathways in Recovery"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/pt-141-post-surgery","role":"explain","audience":"human"},"skill":{"route":"/api/articles/pt-141-post-surgery/skill","role":"direct behavior","audience":"model","content":"---\nname: pt-141-post-surgery\ndescription: Apply the PT-141 for Post-Surgery: Sexual and CNS Arousal Pathways in Recovery article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# PT-141 for Post-Surgery: Sexual and CNS Arousal Pathways in Recovery\n\nThis Skill is the behavioral expression of [the canonical article](/a/pt-141-post-surgery). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/pt-141-post-surgery.\n- Read claims and relationships at /api/articles/pt-141-post-surgery/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nWhat's breaking down Post-surgery recovery often involves layers of change that extend beyond the surgical site itself. Nerve disruption, hormonal shifts, reduced mobility, and psychological stress can affect multiple systems. One relevant \n\n## Representations\n\n- Human: /a/pt-141-post-surgery\n- JSON: /api/articles/pt-141-post-surgery\n- Relationships: /api/articles/pt-141-post-surgery/topology\n- History: /api/articles/pt-141-post-surgery/revisions\n"},"json":{"route":"/api/articles/pt-141-post-surgery","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/pt-141-post-surgery/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["peptide","matrix","pt","141","post","surgery"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/pt-141-post-surgery/invocations?status=success","failure_events":"/api/articles/pt-141-post-surgery/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"pt-141-post-surgery","title":"PT-141 for Post-Surgery: Sexual and CNS Arousal Pathways in Recovery","body":"## What's breaking down\n\nPost-surgery recovery often involves layers of change that extend beyond the surgical site itself. Nerve disruption, hormonal shifts, reduced mobility, and psychological stress can affect multiple systems. One relevant layer for many patients is sexual function and central nervous system (CNS) arousal pathways. Surgery such as prostate procedures can alter nerve signaling and hormone levels, leading to diminished sexual desire even when physical capacity for orgasm remains. This creates a mismatch where mechanical responses may be addressable but the drive and arousal signals from the brain are reduced. The condition persists when repair processes in these neural and motivational pathways lag behind the degenerative effects of the procedure and recovery period.\n\n## Why PT-141 might help you\n\nPT-141 targets the sexual and CNS arousal layer. If that layer is part of your problem after surgery, PT-141 is discussed because it acts on melanocortin receptors in the hypothalamus to enhance arousal signals at the source in the brain.\n\n1. Therefore for you: If your post-surgery experience includes reduced sexual thoughts or motivation despite preserved physical capability, the CNS-focused action aligns with addressing the arousal pathway directly.\n2. Therefore for you: If conventional approaches focus only on blood flow or local tissue, PT-141 operates upstream in the brain, potentially supporting the motivational component of recovery rather than masking symptoms.\n3. Therefore for you: If nerve or hormonal changes from surgery have dampened desire pathways, activating MC4 receptors may promote dopamine release involved in sexual motivation, fitting a repair-oriented discussion of those specific circuits.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- **PT-141** → sexual / CNS arousal\n\n## What the evidence actually shows\n\nHuman data comes primarily from trials in hypoactive sexual desire disorder (HSDD). Two Phase 3 randomized controlled trials (BMT-301 and BMT-302) enrolled over 1,200 premenopausal women and tested subcutaneous bremelanotide 1.75 mg as-needed versus placebo. These showed statistically significant improvements in sexual desire scores and reduced distress compared to placebo (human tier). A long-term open-label extension followed participants for up to 18 months and reported sustained effects with manageable side effects in completers (human tier). Earlier smaller studies measured physiological arousal via vaginal pulse amplitude after erotic stimuli and found greater increases with bremelanotide than placebo in healthy women and those with arousal disorder (human tier, small n).\n\nNo dedicated human trials specifically examine PT-141 after surgery. Mentions of post-prostatectomy use appear in clinical discussion articles but lack controlled data (anecdotal/mechanistic tier). Animal studies demonstrate melanocortin agonism increasing sexual behaviors in rodents via hypothalamic pathways (preclinical tier). These do not directly model human post-surgical states.\n\nReddit anecdotes describe subjective increases in arousal or desire after injection, with onset in 1-6 hours and variable duration, alongside reports of nausea or flushing (anecdotal tier). X posts echo similar user experiences of heightened motivation but remain self-reported without controls.\n\n## What scientists say\n\nResearchers describe bremelanotide as a nonselective melanocortin receptor agonist with primary action at MC4R in the medial preoptic area of the hypothalamus, leading to increased dopamine release in reward and motivation circuits (mechanistic tier from reviews). This central mechanism differentiates it from peripheral vasodilators. Scientists note the absence of large post-surgical human datasets and emphasize that approved use remains limited to HSDD in premenopausal women.\n\n## What people say on Reddit\n\nUsers in peptide communities report trying PT-141 for libido concerns that emerged or persisted after procedures. Common themes include noticeable waves of arousal within hours of dosing and effects lasting into the next day for some. Side-effect mentions frequently include transient nausea, flushing, or headache. Experiences vary widely, with some noting no effect on first use.\n\n## What people say on X\n\nPosts reference personal use for arousal enhancement, often describing rapid onset of sexual thoughts or responsiveness. Timing relative to activity and individual dosing experiments appear frequently. Side-effect discussions mirror Reddit patterns. No large verified threads or expert threads dominate recent activity.\n\n## What we do not know\n\nDirect evidence for PT-141 in post-surgical populations is absent from controlled human trials. Long-term effects on neural repair pathways after surgery remain unstudied. Interactions with common post-operative medications or healing timelines lack specific data. Optimal timing relative to surgical recovery stages is unknown.\n\n## Safety and limits\n\nReported effects in trials include nausea, flushing, and injection-site reactions, with most described as mild to moderate (human tier). The compound carries a boxed warning for blood-pressure increases in its approved formulation. Individual responses differ, and self-experimentation carries unknown risks outside monitored settings. All information here is for research discussion only; consult qualified professionals for personal health decisions.","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/pt-141-post-surgery/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"Two Phase 3 RCTs (BMT-301, BMT-302) showed statistically significant improvements in sexual desire scores with bremelanotide 1.75 mg vs placebo in women with HSDD.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes the primary human efficacy data tier for the compound's approved indication.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:07.221Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"No dedicated randomized human trials examine PT-141 specifically in post-surgical populations.","section":"What we do not know","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Clarifies the evidence gap for the article's specific context.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:07.221Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Bremelanotide acts as an MC4R agonist in the hypothalamus, increasing dopamine release in motivation circuits.","section":"What scientists say","tier":"mechanistic","source_ids":["s3"],"source_status":"sourced","why_material":"Provides the core mechanism explanation tied to the CNS arousal layer.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:07.221Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"User reports on Reddit describe subjective arousal increases 1-6 hours after PT-141 injection with variable side effects like nausea.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s4"],"source_status":"sourced","why_material":"Documents real-world anecdotal layer separate from trials.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:07.221Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"clinical_trial","url":"https://clinicaltrials.gov/study/NCT01382719","title":"Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder","quote":"This trial is designed to evaluate the efficacy and safety of 3 fixed dose levels of bremelanotide...","summary":"Phase 3 trial details supporting HSDD efficacy data.","claim_ids":["c1"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:11:06.835Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"b37ba9f623c01df7436e68e9bf724e6497f8f74017b8f526eb5785cf8b6decf7"},{"id":"s2","type":"other","url":"https://www.bostonmedicalgroup.com/pt-141-low-libido-after-prostate-surgery/","title":"Can the PT-141 Peptide Improve Low Libido After Prostate Surgery?","quote":"In this article, we'll explore whether PT-141 for low libido may help men regain sexual desire...","summary":"Clinical discussion noting post-surgery context but no new trial data.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:11:06.835Z","link_status":"ok","quote_status":"unverified","prev":"b37ba9f623c01df7436e68e9bf724e6497f8f74017b8f526eb5785cf8b6decf7","hash":"e38ee0c5739b289b8e4e11c09c118a17d41103a42c1b6989ecb0686cc871f5c4"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/33455598/","title":"The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder","quote":"Bremelanotide may affect female sexual desire by activating presynaptic MC4Rs on neurons in the mPOA of the hypothalamus, leading to increased release of DA.","summary":"Mechanism review detailing CNS action.","claim_ids":["c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:11:06.835Z","link_status":"ok","quote_status":"unverified","prev":"e38ee0c5739b289b8e4e11c09c118a17d41103a42c1b6989ecb0686cc871f5c4","hash":"f1b595db88fc864cde3f2e5e4b61bea8677f992b83deb6803e64da671e30b253"},{"id":"s4","type":"reddit","url":"https://www.reddit.com/r/Peptides/comments/1f9yows/pt141_major_success/","title":"PT-141 Major Success!","quote":"The effect comes on about 2 hours after injection and goes on strongly for at least 18 hours...","summary":"Example anecdotal report of timing and effects.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:11:06.835Z","link_status":"ok","quote_status":"unverified","prev":"f1b595db88fc864cde3f2e5e4b61bea8677f992b83deb6803e64da671e30b253","hash":"63b723640f12cc821fc5128dce68d3fcd78ec5f9ae67932d7634d70e2c6ae3b6"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T01:11:07.638Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"PT-141 for Post-Surgery: Sexual and CNS Arousal Pathways in Recovery","register":"source_ledger","body":"## What's breaking down\n\nPost-surgery recovery often involves layers of change that extend beyond the surgical site itself. Nerve disruption, hormonal shifts, reduced mobility, and psychological stress can affect multiple systems. One relevant layer for many patients is sexual function and central nervous system (CNS) arousal pathways. Surgery such as prostate procedures can alter nerve signaling and hormone levels, leading to diminished sexual desire even when physical capacity for orgasm remains. This creates a mismatch where mechanical responses may be addressable but the drive and arousal signals from the brain are reduced. The condition persists when repair processes in these neural and motivational pathways lag behind the degenerative effects of the procedure and recovery period.\n\n## Why PT-141 might help you\n\nPT-141 targets the sexual and CNS arousal layer. If that layer is part of your problem after surgery, PT-141 is discussed because it acts on melanocortin receptors in the hypothalamus to enhance arousal signals at the source in the brain.\n\n1. Therefore for you: If your post-surgery experience includes reduced sexual thoughts or motivation despite preserved physical capability, the CNS-focused action aligns with addressing the arousal pathway directly.\n2. Therefore for you: If conventional approaches focus only on blood flow or local tissue, PT-141 operates upstream in the brain, potentially supporting the motivational component of recovery rather than masking symptoms.\n3. Therefore for you: If nerve or hormonal changes from surgery have dampened desire pathways, activating MC4 receptors may promote dopamine release involved in sexual motivation, fitting a repair-oriented discussion of those specific circuits.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- **PT-141** → sexual / CNS arousal\n\n## What the evidence actually shows\n\nHuman data comes primarily from trials in hypoactive sexual desire disorder (HSDD). Two Phase 3 randomized controlled trials (BMT-301 and BMT-302) enrolled over 1,200 premenopausal women and tested subcutaneous bremelanotide 1.75 mg as-needed versus placebo. These showed statistically significant improvements in sexual desire scores and reduced distress compared to placebo (human tier). A long-term open-label extension followed participants for up to 18 months and reported sustained effects with manageable side effects in completers (human tier). Earlier smaller studies measured physiological arousal via vaginal pulse amplitude after erotic stimuli and found greater increases with bremelanotide than placebo in healthy women and those with arousal disorder (human tier, small n).\n\nNo dedicated human trials specifically examine PT-141 after surgery. Mentions of post-prostatectomy use appear in clinical discussion articles but lack controlled data (anecdotal/mechanistic tier). Animal studies demonstrate melanocortin agonism increasing sexual behaviors in rodents via hypothalamic pathways (preclinical tier). These do not directly model human post-surgical states.\n\nReddit anecdotes describe subjective increases in arousal or desire after injection, with onset in 1-6 hours and variable duration, alongside reports of nausea or flushing (anecdotal tier). X posts echo similar user experiences of heightened motivation but remain self-reported without controls.\n\n## What scientists say\n\nResearchers describe bremelanotide as a nonselective melanocortin receptor agonist with primary action at MC4R in the medial preoptic area of the hypothalamus, leading to increased dopamine release in reward and motivation circuits (mechanistic tier from reviews). This central mechanism differentiates it from peripheral vasodilators. Scientists note the absence of large post-surgical human datasets and emphasize that approved use remains limited to HSDD in premenopausal women.\n\n## What people say on Reddit\n\nUsers in peptide communities report trying PT-141 for libido concerns that emerged or persisted after procedures. Common themes include noticeable waves of arousal within hours of dosing and effects lasting into the next day for some. Side-effect mentions frequently include transient nausea, flushing, or headache. Experiences vary widely, with some noting no effect on first use.\n\n## What people say on X\n\nPosts reference personal use for arousal enhancement, often describing rapid onset of sexual thoughts or responsiveness. Timing relative to activity and individual dosing experiments appear frequently. Side-effect discussions mirror Reddit patterns. No large verified threads or expert threads dominate recent activity.\n\n## What we do not know\n\nDirect evidence for PT-141 in post-surgical populations is absent from controlled human trials. Long-term effects on neural repair pathways after surgery remain unstudied. Interactions with common post-operative medications or healing timelines lack specific data. Optimal timing relative to surgical recovery stages is unknown.\n\n## Safety and limits\n\nReported effects in trials include nausea, flushing, and injection-site reactions, with most described as mild to moderate (human tier). The compound carries a boxed warning for blood-pressure increases in its approved formulation. Individual responses differ, and self-experimentation carries unknown risks outside monitored settings. All information here is for research discussion only; consult qualified professionals for personal health decisions.","claims":[{"id":"c1","text":"Two Phase 3 RCTs (BMT-301, BMT-302) showed statistically significant improvements in sexual desire scores with bremelanotide 1.75 mg vs placebo in women with HSDD.","section":"What the evidence actually shows","tier":"human","source_ids":["s1"],"source_status":"sourced","why_material":"Establishes the primary human efficacy data tier for the compound's approved indication.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:07.221Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"No dedicated randomized human trials examine PT-141 specifically in post-surgical populations.","section":"What we do not know","tier":"human","source_ids":["s2"],"source_status":"sourced","why_material":"Clarifies the evidence gap for the article's specific context.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:07.221Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Bremelanotide acts as an MC4R agonist in the hypothalamus, increasing dopamine release in motivation circuits.","section":"What scientists say","tier":"mechanistic","source_ids":["s3"],"source_status":"sourced","why_material":"Provides the core mechanism explanation tied to the CNS arousal layer.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:07.221Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"User reports on Reddit describe subjective arousal increases 1-6 hours after PT-141 injection with variable side effects like nausea.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s4"],"source_status":"sourced","why_material":"Documents real-world anecdotal layer separate from trials.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:07.221Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"clinical_trial","url":"https://clinicaltrials.gov/study/NCT01382719","title":"Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder","quote":"This trial is designed to evaluate the efficacy and safety of 3 fixed dose levels of bremelanotide...","link_status":"ok","quote_status":"unverified"},{"id":"s2","type":"other","url":"https://www.bostonmedicalgroup.com/pt-141-low-libido-after-prostate-surgery/","title":"Can the PT-141 Peptide Improve Low Libido After Prostate Surgery?","quote":"In this article, we'll explore whether PT-141 for low libido may help men regain sexual desire...","link_status":"ok","quote_status":"unverified"},{"id":"s3","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/33455598/","title":"The neurobiology of bremelanotide for the treatment of hypoactive sexual desire disorder","quote":"Bremelanotide may affect female sexual desire by activating presynaptic MC4Rs on neurons in the mPOA of the hypothalamus, leading to increased release of DA.","link_status":"ok","quote_status":"unverified"},{"id":"s4","type":"reddit","url":"https://www.reddit.com/r/Peptides/comments/1f9yows/pt141_major_success/","title":"PT-141 Major Success!","quote":"The effect comes on about 2 hours after injection and goes on strongly for at least 18 hours...","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":24502,"tokens_out":2975,"cost":0.038065,"prev_hash":"genesis","hash":"6fac8f608bac198b5d02b16e9415d326ec35941d73a17612068693f2c9c85d6e"}],"provenance":[{"ts":"2026-06-30T01:11:07.638Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: PT 141 for Post Surgery\nSlug: pt-141-post-surgery\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"pt-141\",\"name\":\"PT-141\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"pt-141\",\"name\":\"PT-141\",\"section_title\":\"Why PT-141 might help you\",\"layer\":\"sexual / CNS arousal\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **PT-141** → sexual / CNS arousal\",\"section_headings\":[\"What's breaking down\",\"Why PT-141 might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not merge into one peptide essay.\",\"Each Why section must use if-then steps from","response":"{\n  \"slug\": \"pt-141-post-surgery\",\n  \"title\": \"PT-141 for Post-Surgery: Sexual and CNS Arousal Pathways in Recovery\",\n  \"body\": \"## What's breaking down\\n\\nPost-surgery recovery often involves layers of change that extend beyond the surgical site itself. Nerve disruption, hormonal shifts, reduced mobility, and psychological stress can affect multiple systems. One relevant layer for many patients is sexual function and central nervous system (CNS) arousal pathways. Surgery such as prostate procedures can alter nerve signaling and hormone levels, leading to diminished sexual desire even when physical capacity for orgasm remains. This creates a mismatch where mechanical responses may be addressable but the drive and arousal signals from the brain are reduced. The condition persists when repair processes in these neural and motivational pathways lag behind the degenerative effects of the procedure and recovery period.\\n\\n## Why PT-141 might help you\\n\\nPT-141 targets the sexual and CNS arousal layer. If that layer is part of your problem after surgery, PT-141 is discussed because it acts on melanocortin receptors in the hypothalamus to enhance arousal signals at the source in the brain.\\n\\n1. Therefore for you: If your post-surgery experience includes reduced sexual thoughts or motivation despite preserved physical capability, the CNS-focused action aligns with addressing the arousal pathway directly.\\n2. Therefore for you: If conventional approaches focus only on blood flow or local tissue, PT-141 operates upstream in the brain, potentially supporting the motivational component of recovery rather than masking symptoms.\\n3. Therefore for you: If nerve or hormonal changes from surgery have dampened desire pathways, activating MC4 receptors may promote dopamine release involved in sexual motivation, fitting a repair-oriented discussion of those specific circuits.\\n\\n## How these fit together\\n\\nSingle-compound focus — if your condition profile includes a multi-peptide sta","tokens_in":24502,"tokens_out":2975,"cost":0,"prev":"genesis","hash":"8cde3da0f7d91cdd6364f726500ed318eff8ebed2e2bc23f37d967b27808a88d"},{"ts":"2026-07-17T02:41:09.189Z","model":"owner","action":"voxel_divide","prompt":"","input":"pt-141-post-surgery","response":"22 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"8cde3da0f7d91cdd6364f726500ed318eff8ebed2e2bc23f37d967b27808a88d","hash":"eb64b4e74da8b513fc0582020abcdd06a15ae3c976eccbe7dc650618dfd4b673"}],"energy":{"passes":2,"tokens_in":24502,"tokens_out":2975,"tokens_total":27477,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"eb64b4e74da8b513fc0582020abcdd06a15ae3c976eccbe7dc650618dfd4b673"},"posted_at":"2026-06-29T21:32:54.884Z","created_at":"2026-06-29T21:32:54.884Z","updated_at":"2026-07-17T02:41:09.189Z","machine":{"shape":"article.machine/v1","slug":"pt-141-post-surgery","kind":"article","read":{"human":"https://miscsubjects.com/a/pt-141-post-surgery","json":"https://miscsubjects.com/api/articles/pt-141-post-surgery","bundle":"https://miscsubjects.com/api/articles/pt-141-post-surgery/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":4,"sources":4,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/pt-141-post-surgery/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=pt-141-post-surgery","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"pt-141-post-surgery\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"pt-141-post-surgery\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/pt-141-post-surgery/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"pt-141-post-surgery\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/pt-141-post-surgery | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/pt-141-post-surgery","json":"/api/articles/pt-141-post-surgery","markdown":"/api/articles/pt-141-post-surgery/bundle?format=markdown","skill":"/api/articles/pt-141-post-surgery/skill","topology":"/api/articles/pt-141-post-surgery/topology","versions":"/api/articles/pt-141-post-surgery/revisions","invocations":"/api/articles/pt-141-post-surgery/invocations"},"editorial_review":null,"editorial_audit":{"slug":"pt-141-post-surgery","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"017d04c9626a675076cb1536225564c787d4219f3427cafb9d02edb2ac8ab73f"}}}